Sponsor:
National Institutes of Health
Updated Date:
Mar 25, 2019
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Notices
- Notice of Special Interest: Development of Cryogenic or Other Long-term Preservation and Revival Methods for Drosophila and Zebrafish Genetic Stocks
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs - The National Institutes of Health (NIH) Office of Disease Prevention (ODP) Announces the Pathways to Prevention Workshop: Achieving Health Equity in Preventive Services
Office of Disease Prevention - Notice of Clarification Regarding the Submission of Biosketches for PA-18-906 "Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)"
National Institutes of Health - Notice of Intent to Publish a Funding Opportunity Announcement for Specialized Alcohol Research Centers (P50 Clinical trial Optional)
National Institute on Alcohol Abuse and Alcoholism - Notice of Change to PAR-17-031 "Role of Age-Associated Metabolic Changes in Alzheimer's Disease (AD) (R01)"
National Institute on Aging - Notice of Change to PAR-18-030 "NIA Revision and Resubmission Program Project Applications (P01 Clinical Trial Optional)"
National Institute on Aging - Notice of Changes to RFA-AI-19-002 "HIV/AIDS Clinical Trials Networks Statistical and Data Management Centers (UM1 Clinical Trial Required)"
National Institute of Allergy and Infectious Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke - Notice of Availability of Administrative Supplements for Geospatial, Multilevel, and Contextual Approaches in Cancer Control and Population Sciences
National Cancer Institute - Notice of Availability of Administrative Supplements to Promote Data Sharing in Cancer Epidemiology Studies
National Cancer Institute - Notice of Special Interest: Administrative Supplements to Support Collaborations with the Drug Resistance and Sensitivity Network (DRSN)
National Cancer Institute - Pre-Application Webinar for NOT-CA-19-031, Notice of Availability of Administrative Supplements to Promote Data Sharing in Cancer Epidemiology Studies
National Cancer Institute - Notice of a Joint Veterans Health Administration/National Cancer Institute Data Science Initiative called the Big Data Scientist Training Enhancement Program (BD-STEP)
National Cancer Institute - Request for Information (RFI): Needs and Challenges in Obtaining and Using Peptides for Translational and Clinical Cancer Research
National Cancer Institute - Request for Proposals (RFP) Notice: Medication Discovery Using Rat Models of Relapse
National Institute on Drug Abuse - Notice of Change in Application Due Dates for PAR-19-030 "NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)"
National Institute of Diabetes and Digestive and Kidney Diseases - Notice of NIEHS Participation on PAR-19-162 "Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) "
National Institute of Environmental Health Sciences - Notice to early expire RFA-FD-19-007 "Conduct Studies to Establish More Targeted Durations of Use for Certain Approved Antimicrobial New Animal Drugs in Food Animals (U01 Clinical Trial Required)"
Food and Drug Administration - NIH Highlights Support for Data Science Research through the Academic Research Enhancement Award (AREA) Program
National Institute of General Medical Sciences
National Cancer Institute
National Human Genome Research Institute
National Institute on Aging
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Library of Medicine - Notice of Special Interest: Availability of Administrative Supplements to INBRE Awards to Fund Research in Collaboration with COBRE or IDeA-CTR Awards
National Institute of General Medical Sciences - Notice of Pre-Application Webinar for PAR-19-218 "Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34)"
National Institute of General Medical Sciences - Notice of Special Interest: SEARCH: Stimulating ExplorAtory Research on HIV/AIDS Contribution to Heart, Lung, Blood and Sleep Comorbidities (R01 - Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute - Notice of Special Interest (NOSI): Bold New Bioengineering Research for Heart, Lung, Blood and Sleep Disorders and Diseases
National Heart, Lung, and Blood Institute - Notice of Special Interest in Research on the Health of Sexual and Gender Minority (SGM) Populations
National Institute on Minority Health and Health Disparities
National Center for Complementary and Integrative Health
National Cancer Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Science Research
Office of the Director, NIH
Office of Disease Prevention
Office of Research on Women's Health - Notice of Information: Clinical Trials that Explore Non-Addictive Therapeutics for Pain Conditions under the Early Phase Pain Investigation Clinical Network (EPPIC-Net)
National Institute of Neurological Disorders and Stroke - Request for Information: Soliciting Input on How Best to Advance Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Research
National Institute of Neurological Disorders and Stroke - Notice of Change to Key Date for PAR-19-170 "Progression Markers for Cognitive Impairment in Parkinson's Disease Dementia (R01 Clinical Trial Not Allowed)".
National Institute of Neurological Disorders and Stroke - Notice of Change to Key Date for PAR-19-167 "Development and Validation of Advanced Mammalian Models for Alzheimer's Disease-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed)".
National Institute of Neurological Disorders and Stroke - Notice of a Parallel Funding Opportunity Announcement by the Canadian Institutes of Health Research Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA)
National Institute of Neurological Disorders and Stroke - New Deadline for Proposals to Collaborate with the NIH Common Fund Regenerative Medicine Programs (RMP) Stem Cell Translation Laboratory (SCTL)
Office of Strategic Coordination (Common Fund) - Notice of Change to FOA PAR-19-100: Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional)
National Center for Advancing Translational Sciences
Requests for Applications
- U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (HIV/AIDS) (R01 Clinical Trial Optional)
National Institute of Allergy and Infectious Diseases
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
- U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (HIV/AIDS) (U01 Clinical Trial Optional)
National Institute of Allergy and Infectious Diseases
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (R01 Clinical Trial Optional)
- U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (U01 Clinical Trial Optional)
National Institute of Allergy and Infectious Diseases
- Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20 Clinical Trial Optional)
National Cancer Institute
- Kidney Technology Development Research Education Program (R25 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
- Conduct Studies to Establish More Targeted Durations of Use for Certain Approved Antimicrobial New Animal Drugs in Food Animals (U01 Clinical Trial Required)
Food and Drug Administration. - Implementation of the Animal Feed Regulatory Program Standards (U18 Clinical Trial Not Allowed)
Food and Drug Administration
- Medical Rehabilitation Research Resource (P2C Clinical Trial Optional)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
- Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) (UG3/UH3 Clinical Trial Optional)
- Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) - Research Coordinating Center (RCC) (U24 Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute
- BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa (UG3/UH3 Clinical Trial Optional)
- BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa - Data Coordinating Center (DCC) (U24 Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute
Program Announcements
- Administrative Supplement for Research on Bioethical Issues
National Institutes of Health
John E. Fogarty International Center
National Center for Advancing Translational Sciences
National Cancer Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
- Advancing Manufacturing Processing and Control Strategies for Drug Substances and Drug Products (U01)- Clinical Trial Optional
Food and Drug Administration
- Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Lynn Hudachek at lynn-hudachek @uiowa.edu, or Erin Brothers at erin-brothers@uiowa.edu